| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4500bc7f9251b4869af20965162f0f94 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2008-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_633fd434d6256dbcf41c6618ce0f3235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab5961e7e0e36ec3e70bd706f7f5611d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_969895e93b669515fa43718a8b6f514a |
| publicationDate |
2012-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NZ-579609-A |
| titleOfInvention |
Intravesical apaziquone administration following transurethral resection for treating cancer |
| abstract |
Disclosed is a use of a therapeutic amount of apaziquone for manufacturing a medicament for administration within about 6 hours following transurethral resection of bladder tumour (TUR-BT) for treating a bladder cancer. Apaziquone is also known as E09 or NSC-382459 and is 5-(aziridin-1-yl)-3-(hydroxymethyl)-2-[(1E)-3-hydroxyprop-1-enyl]-1-methyl-1H-indole-4,7-dione with the structural formula as depicted. |
| priorityDate |
2007-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |